Patent Assignment
Reel/Frame 036776/0261
Assignment of Assignor's Interest
Recorded: 2015-10-13
Pages: 5
Assignor
LEO OSPREY LIMITED
Executed: 2015-03-02
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties
(8)
Heterocyclic compounds
Application:
10/342,810 →
Publication:
US 2003/0176451
Treatment of cancers expressing p95 erbb2
Application:
10/567,012 →
Publication:
US 2006/0204966
Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors
Application:
11/532,926 →
Publication:
US 2007/0015775
Cancer Treatment Method
Application:
11/548,413 →
Publication:
US 2007/0148261
Quinazoline Ditosylate Salt Compounds
Application:
11/558,616 →
Publication:
US 2008/0058519
Cancer Treatment Method
Application:
12/094,687 →
Publication:
US 2009/0005406
Chemical Compounds
Application:
12/609,398 →
Publication:
US 2010/0105712
Treatment of Cancers Expressing p95 ErbB2
Application:
14/662,452 →
Publication:
US 2015/0190397
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 29, 2006
From: SMITHKLINE BEECHAM CORPORATION
To: SMITHKLINE BEECHAM (CORK) LIMITED
Reel/Frame 018184/0080 →
Assignment of Assignor's Interest
Dec 20, 2006
From: SMITHKLINE BEECHAM (CORK) LIMITED
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 018654/0335 →
Assignment of Assignor's Interest
Mar 19, 2015
From: SPECTOR, NEIL LEE; XIA, WENLE
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 035203/0133 →
Assignment of Assignor's Interest
Oct 13, 2015
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 036908/0903 →
Assignment of Assignor's Interest
Oct 13, 2015
From: GLAXOSMITHKLINE LLC
To: LEO OSPREY LIMITED
Reel/Frame 036776/0254 →